LAVA Medtech Acquisition Corp. Class A Common Stock
LVAC
LVAC was delisted on the 10th of May, 2023.
18 hedge funds and large institutions have $45.1M invested in LAVA Medtech Acquisition Corp. Class A Common Stock in 2021 Q4 according to their latest regulatory filings, with 18 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BCM
Beryl Capital Management
Redondo Beach,
California
|
+$9.89M |
| 2 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
+$7.4M |
| 3 |
SCM
Saba Capital Management
New York
|
+$5.28M |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
+$3.71M |
| 5 |
WAM
Wolverine Asset Management
Chicago,
Illinois
|
+$3.06M |
Top Sellers
LVAC Hedge Fund Activity: Q4 2021 in Review
18 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in LAVA Medtech Acquisition Corp. Class A Common Stock (LVAC) for Q4 2021, worth a combined $45.1M.
Buyers outnumbered sellers: 18 funds opened new LVAC positions and 0 closed out — a net gain of 18 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Beryl Capital Management, opening a new position worth an estimated $9.89M.
- 18 institutional investors held LAVA Medtech Acquisition Corp. Class A Common Stock (LVAC) as of Q4 2021, up from 0 in Q3 2021.
- Funds reported $45.1M of LAVA Medtech Acquisition Corp. Class A Common Stock stock for Q4 2021.
- 18 funds opened new LAVA Medtech Acquisition Corp. Class A Common Stock positions in Q4 2021 and 0 closed out, a net change of +18 holders.
- The largest LAVA Medtech Acquisition Corp. Class A Common Stock buyer in Q4 2021 was Beryl Capital Management, an estimated $9.89M added.
Based on aggregated 13F filings for Q4 2021.